Core Insights - The animal health sector experienced a slight increase of 0.55% on November 7, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 3997.56, down 0.25%, while the Shenzhen Component Index closed at 13404.06, down 0.36% [1] Stock Performance - *ST Lvkang (002868) closed at 31.76, up 4.99% with a trading volume of 12,000 hands and a transaction value of 37.6483 million yuan [1] - Other notable stocks included: - Biological Shares (600201) at 10.52, up 1.64% with a trading volume of 234,300 hands [1] - Driving Force (920275) at 9.88, up 1.13% with a trading volume of 7,484 hands [1] - Zhongmu Shares (600195) at 7.75, up 0.65% with a trading volume of 77,200 hands [1] Capital Flow - The animal health sector saw a net outflow of 5.144 million yuan from institutional investors, while retail investors experienced a net outflow of 11.0652 million yuan [2] - Conversely, speculative funds recorded a net inflow of 16.2092 million yuan [2] Detailed Capital Flow Analysis - Major stocks and their capital flow included: - Biological Shares (600201) with a net inflow of 20.3753 million yuan from institutional investors [3] - *ST Lvkang (002868) had a net inflow of 2.9042 million yuan from institutional investors [3] - Huisheng Biological (300871) faced a significant net outflow of 18.6925 million yuan from institutional investors [3]

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-114 绿康生化股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要提示： 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于 2025 年 11 月 5 日召开的第五届董事会第二十四次（临时）会议审议通过了《关于召开 2025 年第四次临时股东会的议案》，决定于 2025 年 11 月 24 日 15:00 召开公 司 2025 年第四次临时股东会。现将具体事项通知如下： 一、召开会议的基本情况 1、股东会届次：2025 年第四次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所股票上市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上 市公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》 的有关规定。 4、会议时间： （1）现场会议时间：2025 年 11 月 24 日 15:00 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的 ...

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-115 绿康生化股份有限公司 关于公司向银行申请授信及担保资产调整的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、概述 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）于 2023 年 02 月 21 日召开第四届董事会第二十二次（临时）会议审议通过了《关于向银行等 金融机构申请综合授信额度的议案》，并授权其法定代表人与银行等金融机构签 署上述授信融资事项下的有关法律文件。同意公司向中信银行股份有限公司南昌 分行（以下简称"中信银行"）及下属分支机构申请并购贷款壹亿陆仟万元整， 并用持有被并购子公司绿康（玉山）胶膜材料有限公司（以下简称"绿康玉山"， 由江西纬科新材料科技有限公司更名而来）100%股权进行质押。详见 2023 年 8 月 30 日在《证券日报》和巨潮资讯网（http://www.cninfo.com.cn）披露的《关于 公司向银行申请授信的进展暨申请并购贷并质押全资子公司股权的公告》（公告 编号：2023-098）。 二、进展暨担保资产调整的情况 针对上述借款 ...

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-113 绿康生化股份有限公司 关于向公司关联方借款暨关联交易的公告 本次关联交易不属于《上市公司重大资产重组管理办法》规定的重大资产重 组、不构成重组上市，不需要经过有关部门批准。根据《深圳证券交易所股票上 市规则》第 6.3.10 条规定，关联人向上市公司提供资金，利率不高于中国人民 银行规定的贷款市场报价利率，且上市公司无相应担保，可豁免提交股东会审议， 经审慎性考虑，公司自愿将本次关联交易提交公司股东会审议。 二、关联方基本情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、关联交易概述 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）拟向福建纵腾 网络有限公司（以下简称"纵腾网络"）借入 15,000 万元，用途为公司日常经 营。借款期限为：自纵腾网络向绿康生化付款之日起至 2026 年 12 月 31 日。尽 管有前述约定，双方同意，如纵腾网络与上海康怡投资有限公司、上饶市长鑫贰 号企业管理中心（有限合伙）、杭州义睿投资合伙企业（有限合伙）及杭州皓赢 投资合伙企业（有限合 ...

第五届监事会第十七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）第五届监事会 第十七次会议于 2025 年 11 月 5 日以现场方式在公司综合办公楼二楼第二会议室 召开，会议通知已按照《公司章程》及《公司监事会议事规则》要求发出。本次 监事会应参加会议监事 3 人，实际出席监事 3 人。会议由监事会主席冯真武先生 主持召开。会议的召集、召开、表决程序符合《中华人民共和国公司法》和《公 司章程》的规定。 二、监事会会议审议情况 1、审议通过了《关于向公司关联方借款暨关联交易的议案》 监事在审议过程中，对此次借款的必要性、借款利率合理性等方面进行了充 分讨论，认为该事项符合公司战略发展方向，未发现损害公司及中小股东利益的 情形，一致同意该议案。 证券代码：002868 证券简称：*ST 绿康 公告编号：2025-112 绿康生化股份有限公司 具 体 内 容 详 见 公 司 同 日 披 露 于 《 证 券 日 报 》 和 巨 潮 资 讯 网 （http://www.cn ...

证券代码：002868 证券简称：*ST 绿康 公告编号：2025-111 绿康生化股份有限公司 第五届董事会第二十四次（临时）会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 绿康生化股份有限公司（以下简称"公司"或"绿康生化"）第五届董事会 第二十四次（临时）会议于 2025 年 11 月 5 日在公司综合办公楼二楼第一会议室 以现场结合通讯会议方式召开，会议通知已按照《公司章程》及《公司董事会议 事规则》要求发出。本次董事会应到董事 7 人，实到董事 7 人，其中独立董事 3 人。本次会议由董事长赖潭平先生主持召开。本次会议的召集、召开、表决程序 符合《中华人民共和国公司法》和《公司章程》的规定，所作决议合法有效。 二、董事会会议审议情况 1、审议通过了《关于向公司关联方借款暨关联交易的议案》 同意公司向关联方福建纵腾网络有限公司（以下简称"纵腾网络"）借入 15,000 万元，用于公司日常生产经营使用，借款期限为：自纵腾网络向绿康生化 付款之日起至 2026 年 12 月 31 日。尽管有前述约定，双方同意，如纵腾网 ...

Core Insights - The animal health sector experienced a slight increase of 0.36% on November 6, with *ST Lvkang leading the gains [1] - The Shanghai Composite Index closed at 4007.76, up 0.97%, while the Shenzhen Component Index closed at 13452.42, up 1.73% [1] Stock Performance - *ST Lvkang (002868) closed at 30.25, with a rise of 5.00% and a trading volume of 32,200 hands, amounting to a transaction value of 96.94 million yuan [1] - Other notable stocks include: - KQ Bio (688526) at 16.07, up 0.69% [1] - Biological Shares (600201) at 10.35, up 0.68% with a transaction value of 153 million yuan [1] - Ruipu Biological (300119) at 20.46, up 0.20% [1] - Pulaike (603566) at 14.09, up 0.14% [1] Capital Flow - The animal health sector saw a net outflow of 17.47 million yuan from institutional investors, while retail investors contributed a net inflow of 8.89 million yuan [2] - The capital flow for individual stocks indicates: - *ST Lvkang had a net inflow of 7.56 million yuan from institutional investors [3] - KQ Bio experienced a net inflow of 4.84 million yuan [3] - Biological Shares had a net inflow of 2.64 million yuan [3]

Core Insights - The animal health sector experienced a decline of 0.35% on November 3, with Reap Bio leading the losses [1] - The Shanghai Composite Index closed at 3976.52, up 0.55%, while the Shenzhen Component Index closed at 13404.06, up 0.19% [1] Stock Performance Summary - Hai Li Biological (603718) closed at 7.02, up 2.03% with a trading volume of 101,600 shares and a turnover of 70.93 million yuan [1] - Shen Lian Biological (688098) closed at 11.36, up 1.43% with a trading volume of 133,100 shares and a turnover of 150 million yuan [1] - Yong Shun Biological (920729) closed at 10.09, up 1.00% with a trading volume of 23,800 shares and a turnover of 24.09 million yuan [1] - The worst performer was Reap Bio (300119), which closed at 21.01, down 2.51% with a trading volume of 103,300 shares and a turnover of 219 million yuan [2] Capital Flow Analysis - The animal health sector saw a net outflow of 35.26 million yuan from institutional investors, while retail investors had a net inflow of 26.79 million yuan [2] - The main capital inflow was observed in Shen Lian Biological, with a net inflow of 4.03 million yuan from institutional investors [3] - Conversely, Reap Bio experienced a net outflow of 1.29 million yuan from institutional investors [3]

Market Overview - The animal health sector experienced a decline of 2.79% on October 30, with Jinhe Biology leading the drop [1] - The Shanghai Composite Index closed at 3986.9, down 0.73%, while the Shenzhen Component Index closed at 13532.13, down 1.16% [1] Individual Stock Performance - Jinhe Biology (002688) closed at 6.25, down 7.13% with a trading volume of 578,000 shares and a transaction value of 367 million yuan [1] - Keqian Biology (688526) closed at 16.15, down 6.76% with a trading volume of 139,800 shares and a transaction value of 228 million yuan [1] - Maofeng Holdings (002141) closed at 3.92, down 5.08% with a trading volume of 461,300 shares and a transaction value of 18.3 million yuan [1] - Other notable declines include Dayu Biology (920970) down 2.69%, and Pulaike (603566) down 2.68% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 84.7 million yuan from institutional investors, while retail investors experienced a net outflow of 16.5 million yuan [1] - Speculative funds recorded a net inflow of 101 million yuan [1] Detailed Capital Flow for Selected Stocks - Keqian Biology (688526) had a net inflow of 39.6 million yuan from institutional investors, while retail investors saw a net outflow of 60.9 million yuan [2] - Huisheng Biology (300871) experienced a net inflow of 18.3 million yuan from institutional investors, with a net outflow of 21.2 million yuan from retail investors [2] - Other stocks like Pulaike (603566) and Maofeng Holdings (002141) also reported significant net outflows from institutional investors [2]

Core Viewpoint - The animal health sector experienced a slight increase of 0.21% on October 24, with significant contributions from specific stocks, particularly Biological Shares, which led the gains [1] Market Performance - The Shanghai Composite Index closed at 3950.31, up 0.71% - The Shenzhen Component Index closed at 13289.18, up 2.02% [1] Stock Performance in Animal Health Sector - Biological Shares (600201) closed at 10.77, up 2.87% with a trading volume of 311,900 shares and a turnover of 333 million yuan - Other notable stocks include: - *ST Green Health (002868): closed at 29.09, up 0.66% - Shunlian Biological (688098): closed at 10.75, up 0.66% - Huisheng Biological (300871): closed at 20.75, up 0.48% - Yongshun Biological (920729): closed at 9.68, up 0.31% - Jinhe Biological (002688): closed at 6.68, unchanged [1] Capital Flow Analysis - The animal health sector saw a net inflow of 8.6031 million yuan from institutional investors, while retail investors experienced a net outflow of 24.4195 million yuan [2] - The breakdown of capital flow indicates: - Repu Biological (300119) had a net inflow of 9.2707 million yuan from institutional investors - Biological Shares (600201) saw a net inflow of 8.4244 million yuan - Kexin Biological (688526) had a net inflow of 5.4428 million yuan from institutional investors [3]